KN060 Clinical Trials
2 recruitingDrug
Phase 12Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients
End-Stage Renal Disease Requiring Haemodialysis
Suzhou Alphamab Co., Ltd.12 enrolled1 locationNCT07201467
Recruiting
Phase 1
To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension
Hypertension
Suzhou Alphamab Co., Ltd.60 enrolled1 locationNCT07191899